These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

383 related items for PubMed ID: 29873591

  • 21. FbaA- and M protein-based multi-epitope vaccine elicits strong protective immune responses against group A streptococcus in mouse model.
    Ma C, Liu Z, Li W, Qian X, Zhang S, Gao X, Jiang S, Wei L.
    Microbes Infect; 2014 May; 16(5):409-18. PubMed ID: 24704476
    [Abstract] [Full Text] [Related]

  • 22. Synthesis and in vivo studies of carbohydrate-based vaccines against group A streptococcus.
    Simerska P, Abdel-Aal AB, Fujita Y, Batzloff MR, Good MF, Toth I.
    Biopolymers; 2008 May; 90(5):611-6. PubMed ID: 18381625
    [Abstract] [Full Text] [Related]

  • 23. Bactericidal activity of M protein conserved region antibodies against group A streptococcal isolates from the Northern Thai population.
    Yoonim N, Olive C, Pruksachatkunakorn C, Pruksakorn S.
    BMC Microbiol; 2006 Aug 09; 6():71. PubMed ID: 16895610
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Group A streptococcus epidemiology and vaccine implications.
    Cohen-Poradosu R, Kasper DL.
    Clin Infect Dis; 2007 Oct 01; 45(7):863-5. PubMed ID: 17806050
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Preclinical immunogenicity and safety of a Group A streptococcal M protein-based vaccine candidate.
    Batzloff MR, Fane A, Gorton D, Pandey M, Rivera-Hernandez T, Calcutt A, Yeung G, Hartas J, Johnson L, Rush CM, McCarthy J, Ketheesan N, Good MF.
    Hum Vaccin Immunother; 2016 Dec 01; 12(12):3089-3096. PubMed ID: 27541593
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Intranasal vaccination with a lipopeptide containing a conformationally constrained conserved minimal peptide, a universal T cell epitope, and a self-adjuvanting lipid protects mice from group A streptococcus challenge and reduces throat colonization.
    Batzloff MR, Hartas J, Zeng W, Jackson DC, Good MF.
    J Infect Dis; 2006 Aug 01; 194(3):325-30. PubMed ID: 16826480
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Novel platform technology for modular mucosal vaccine that protects against streptococcus.
    Zaman M, Ozberk V, Langshaw EL, McPhun V, Powell JL, Phillips ZN, Ho MF, Calcutt A, Batzloff MR, Toth I, Hill GR, Pandey M, Good MF.
    Sci Rep; 2016 Dec 15; 6():39274. PubMed ID: 27976706
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.